GGiantBullStocks

GeneDx Holdings Corp. - Class A (WGS)

NASDAQ · Healthcare

$60.65-4.46%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$1.95B
P/E ratio
EPS
Volume
484,356
52-week high
52-week low
Open
$63.40
Day high
$63.53
Day low
$60.61

Financial highlights

Fiscal yearRevenueNet incomeEPS
2025$427.54M-$21.02M-$0.73
2024$305.45M-$52.29M-$1.94
2023$202.57M-$175.77M-$7.23
2022$234.69M-$548.98M-$53.63
2021$212.2M-$245.39M-$2.27

About GeneDx Holdings Corp. - Class A

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

CEO
Katherine A. Stueland
Employees
1,300
Country
US
IPO date
Nov 4, 2020

Similar stocks

Other Healthcare companies

Frequently asked questions

What is GeneDx Holdings Corp. - Class A's stock price today?
WGS is trading at $60.65 as of Jul 20, 2026.
What is GeneDx Holdings Corp. - Class A's market cap?
GeneDx Holdings Corp. - Class A (WGS) has a market capitalization of $1.95B.
Does GeneDx Holdings Corp. - Class A pay a dividend?
GeneDx Holdings Corp. - Class A did not pay a dividend in its most recent reported fiscal year.
What sector is GeneDx Holdings Corp. - Class A in?
GeneDx Holdings Corp. - Class A operates in the Healthcare sector.